As­traZeneca’s Pas­cal So­ri­ot says new rise in pay is ‘re­al­ly about’ po­ten­tial suc­ces­sor

As­traZeneca CEO Pas­cal So­ri­ot vig­or­ous­ly de­fend­ed his re­cent­ly se­cured $23.5 mil­lion pay pack­age, cit­ing the UK phar­ma’s need to com­pete for tal­ent.

“It re­al­ly is about mak­ing the com­pa­ny com­pet­i­tive and at­trac­tive for my suc­ces­sor,” So­ri­ot said dur­ing the com­pa­ny’s first-quar­ter earn­ings call with the press. “I in­tend to be here for a while but, of course, at some point, there will be a suc­ces­sor,” he added.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER